Navigation Links
Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement
Date:4/16/2008

NATICK, Mass. and SAN DIEGO, Calif., April 16 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) and CryoCor, Inc. (Nasdaq: CRYO) today announced the signing of a definitive merger agreement, under which Boston Scientific will pay a cash purchase price of $1.35 per share of CryoCor, or approximately $17.6 million. This acquisition follows a development agreement, in place since June 2007, to pursue therapeutic solutions for atrial fibrillation, or "Afib." Afib is the most common cardiac arrhythmia and affects millions of patients.

The existing development agreement involves the development of a console to deliver cryo energy to Boston Scientific's proprietary cryo balloon catheter. Boston Scientific's cryo balloon is being developed to provide a safe, standardized and broadly applicable method to isolate the electrical activity originating from the pulmonary veins, which are believed to be a source for the initiation and propagation of Afib.

"In the current development project, CryoCor's console demonstrated its ability to efficiently deliver nitrous oxide to our proprietary cryo balloon catheter," said Fred Colen, Executive Vice President, Operations and Technology, Boston Scientific Cardiac Rhythm Management. "This acquisition will allow us to further refine this base console technology, and gaining exclusive rights to CryoCor's family of intellectual property will provide us a key strategic advantage. This is a good example of our Cardiac Rhythm Management and Electrophysiology teams w
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
...O, Sept. 29 Cadence Pharmaceuticals,Inc. (Nasdaq:...n-licensing,developing and commercializing proprie... hospital setting, announced today that the compan...ent the company,s corporate,overview on Monday, Oc...me),during the JMP Securities Third Annual Healthc...
...ology Medicaid Fraud Case; Qui Tam Whistleblower A...nt With Client,s Off-Label Marketing, Allegations ...llion Civil Settlement, $50 Million Corpor...Biotech drug manufacturer,Cephalon, Inc. ("Cephalo...or years by off-label marketing its first three pr...
..., Fla., Sept. 29 CPC of America, Inc.,(OTC Bullet...ained FTI,Capital Advisors, LLC, the investment ba...e strategic alternatives for the Company., As CPC...ors will report,to the Board any expressions of in...ible licensing agreement or acquisition of the Com...
Other Biology Technology:Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference 2$425 Million Cephalon Civil Settlement and Criminal Fine; In America's Largest 2$425 Million Cephalon Civil Settlement and Criminal Fine; In America's Largest 3CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities 2
(Date:12/3/2009)...h researchers have measured CO2 levels for the pas...) over a sparsely inhabited rural area near Vallad...nd in the Iberian Peninsula, show that the levels ...r recent years, physicists and meteorologists have...) levels, and how these have evolved in the tropos...
(Date:12/2/2009)...ELPHIA Children exposed to secondhand cigarette s...cer in adulthood, even if they never smoked. , R...emiology, Biomarkers & Prevention , a journal of t...rt of a special tobacco focus in the December issu...s will be diagnosed with lung cancer; more than 15...
(Date:12/2/2009)...ELPHIA People who smoke their first cigarette wit...s of cotinine, a by-product of nicotine when proce...gardless of the number of cigarettes smoked. , ... of lung cancer, our results suggest that smokers ...ly at risk for lung cancer," said researcher Joshu...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Increased nicotine levels detected in those who light-up earlier 2Local farmers in Africa to benefit from school meal programs 59518 1Local farmers in Africa to benefit from school meal programs 59518 2Local farmers in Africa to benefit from school meal programs 59518 3 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 1 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 2 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 3New mathematical model more accurately diagnoses acute heart failure in emergency rooms 59514 1New mathematical model more accurately diagnoses acute heart failure in emergency rooms 59514 2
...ue, Czech Republic A new clinical trial suggests ...y used to treat hypertension, may significantly re...elated report by Penicka et al, "The effects of ca...tion in non-obstructive hypertrophic cardiomyopath...ary issue of The Journal of Molecular Diagnostics...
...ing at structures only atoms across, researchers h...l virus nanomotor. , Because of the motor,s stren...w findings could inspire engineers designing sophi...er of virus types may possess a similar motor, inc...ay also assist pharmaceutical companies developing...
... NEW YORK (DECEMBER 26, 2008) A team of ...vation Society (WCS) has reported a rapid recovery...he tsunami that devastated coastal regions through... The WCS team, working in conjunction with ...ce for Coral Reef Studies (ARCCoERS) along with go...
Other Biology News:Viruses, start your engines! 2Viruses, start your engines! 34 years after tsunami: Corals stage comeback 24 years after tsunami: Corals stage comeback 3
...The CopyControl™ vector can be induced prior t...ctors provide the stability of single-copy BACs wi...r cloning vectors. The kits provide the linearized..., insert size screening system) necessary to creat...
Cell Wall Degrading Enzyme Complex Aspergillus sp. from Sigma-Aldrich
...Templates rich in GC content or with significant s...lify, and when subjected to PCR result in little o...an be increased by the addition of enhancing agent...an effective PCR enhancer for GC-rich templates.,...
...Application: The simple three step procedure (PCR,...sformation) can be completed in one day. The typic... than 80%. , Features and Benefits: , , Universal ...ector , High Cloning Efficiency - Typically>80% , ...
Biology Products: